StonvexLoading…
StonvexStonvexStonvexCore line items from EVI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $389.83M | $353.56M | $354.17M | $267.32M |
Operating Income | $13.77M | $11.63M | $16.51M | $6.39M |
Net Income | $7.50M | $5.65M | $9.72M | $4.09M |
EPS (Diluted) | $0.49 | $0.37 | $0.67 | $0.29 |
Total Assets | $307.03M | $230.66M | $253.85M | $230.77M |
Total Liabilities | $163.55M | $94.05M | $122.89M | $113.09M |
Cash & Equivalents | $8.85M | $4.56M | $5.92M | $3.97M |
Free Cash Flow OCF − CapEx | $16.40M | $27.79M | $-2.77M | $-5.88M |
Shares Outstanding | 13.16K | 13.22K | 12.80K | 12.65M |